MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Clinical heterogeneity of excessive daytime sleepiness in Parkinson’s disease

O. Levin, O. Iakovleva, M. Poluektov (Moscow, Russian Federation)

Meeting: 2018 International Congress

Abstract Number: 1615

Keywords: Autonomic dysfunction, Excessive daytime sleepiness(EDS)

Session Information

Date: Monday, October 8, 2018

Session Title: Parkinson's Disease: Non-Motor Symptoms

Session Time: 1:15pm-2:45pm

Location: Hall 3FG

Objective: To examine reasons and associated clinical features of excessive daytime sleepiness (EDS) in patients with Parkinson’s disease (PD).

Background: Patients with EDS can divided into clinical subgroups depend on its origin. These subgroups are associated with combinations of PD symptoms, which can help to distinguish them and find out the reason of EDS.

Methods: PD patients [N=61 (34M); 63,9±6,4 years old; 4,5±3,2 (0.3-12) years motor disease duration, HY range 1-3, mean MoCA score 25.6±1.8 (22-29)] underwent clinical evaluation including the Hoehn and Yahr scale, the MDS-UPDRS, the scale of autonomic dysfunction in PD (Levin, 2003), the Epworth Sleepiness Scale (ESS), the Parkinson’s disease sleep scale – 2 (PDSS-2). 31 patients with EDS underwent one-night video-polysomnography study and the multiple sleep latency test (MSLT).

Results: Out of the 61 patients, 67,2% had EDS (PD-EDS). There were male predominance (28M versus 13M, p=0,016), longer therapy duration (4,1±3,3 versus 2,1±2,7 years, p=0,01) and higher levodopa equivalent dose (LED) (623,8±323,4 versus 452,0±199,7 mg, p=0,03) in PD-EDS. EDS was associated with extracampine hallucinations (p=0,02), circadian disorders (p<0,05) and postprandial hypotension (PH) (p<0,05). PD-EDS was divided into three groups by results of sleep investigation: 1 – pure EDS (n=15), 2 – moderate and severe obstructive sleep apnea syndrome (OSAS) (n=8), 3 – patients with negative MSLT and subjective sleepiness due to orthostatic hypotension (OH) and/or PH (n=8). The highest ESS scores were in group 2 (14,2±3,7) in comparison with group 1 (10,4±4,1, p=0,02) and group 3 (10,4±3,9, p>0,05). Patients in group 2 had the highest BMI – 33,7±5,3 kg/m2 in comparison with group 1 – 27,1±3,3 kg/m2 and group 3 – 23,1±2,3 kg/m2 (p<0,05). Group 3 had more prominent autonomic dysfunction in comparison with group 1 (p=0,0003), OH was more frequent in this group (p<0,025).

Conclusions: EDS was found in 67% of patients. Risk factors for EDS were male sex, longer therapy duration, high LED, extracampine hallucinations, high BMI and PH. Pure EDS was found in 48%, OSAS lead to EDS in 26%. Complaints about EDS were related with autonomic cardiovascular dysfunction in 26%. High ESS score and high BMI were strongly associated with OSAS. OH, high score of the scale of autonomic dysfunction, low BMI were prognostic factors for subjective sleepiness.

To cite this abstract in AMA style:

O. Levin, O. Iakovleva, M. Poluektov. Clinical heterogeneity of excessive daytime sleepiness in Parkinson’s disease [abstract]. Mov Disord. 2018; 33 (suppl 2). https://www.mdsabstracts.org/abstract/clinical-heterogeneity-of-excessive-daytime-sleepiness-in-parkinsons-disease/. Accessed May 18, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/clinical-heterogeneity-of-excessive-daytime-sleepiness-in-parkinsons-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
      • Welcome to the MDS Abstracts Site
      • Effect of marijuana on Essential Tremor: A case report
      • Advanced Search
      • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
      • Covid vaccine induced parkinsonism and cognitive dysfunction
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley